Will the price of trametinib and dabrafenib be reduced in 2024? Come and find out quickly

Trametinib (Trametinib) is a targeted therapy that is taken with another drug called dabrafenib. It is used to treat many types of cancer that have a certain mutation called a BRAF mutation. Trametinib is a tablet that is taken by mouth once daily. This drug can cause side effects such as diarrhea, rash, and high blood sugar. Although there are few studies on the molecular mechanisms underlying the antitumor effects of trametinib, recent clinical reports have confirmed that its use alone or in combination produces safe and effective antiglioma effects. However, no research on its anti-tumor mechanism has been reported.

The original drug of trametinib has been launched in China and is included in the scope of medical insurance. Only patients who meet the indications can choose to reimburse. SpecificationsThe price of 2mg*30 tablets is more than 10,000 yuan, and the specification is 0. The price of 5mg*30 tablets is more than 5,000 yuan, which is very expensive. This drug may be sold in domestic hospitals or pharmacies. There is currently no specific information about the price reduction of trametinib, but the price after reimbursement will be lower than the original price.

The original drug of Trametinib sold overseas, specificationsThe price of 2mg*30 tablets is more than 7,000 yuan (the price may fluctuate due to the exchange rate). There are also generic trametinib drugs produced in other countries overseas, and their drug ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 2mg*30 tablets of generic drugs produced by Laos Pharmaceutical Factory is more than 2,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap. For overseas drug information and specific prices, please consult Yaode Medical Consultant.